abstract |
Combination therapy for the treatment of cancer is disclosed. The method comprises administering to a cancer patient a therapeutically effective amount of trans- [tetrachlorobis (1H-indazole) ruthenate (III)] or a pharmaceutically acceptable salt thereof, and wherein the patient has a therapeutically effective amount of Administering one or more anticancer agents. |